Daily Papers

An effective method for cross-lingual transfer is to fine-tune a bilingual or multilingual model on a supervised dataset in one language and evaluating it on another language in a zero-shot manner. Translating examples at training time or inference time are also viable alternatives. However, there are costs associated with these methods that are rarely addressed in the literature. In this work, we analyze cross-lingual methods in terms of their effectiveness (e.g., accuracy), development and deployment costs, as well as their latencies at inference time. Our experiments on three tasks indicate that the best cross-lingual method is highly task-dependent. Finally, by combining zero-shot and translation methods, we achieve the state-of-the-art in two of the three datasets used in this work. Based on these results, we question the need for manually labeled training data in a target language. Code and translated datasets are available at https://github.com/unicamp-dl/cross-lingual-analysis

Many companies use large language models (LLMs) offered as a service, like OpenAI's GPT-4, to create AI-enabled product experiences. Along with the benefits of ease-of-use and shortened time-to-solution, this reliance on proprietary services has downsides in model control, performance reliability, uptime predictability, and cost. At the same time, a flurry of open-source small language models (SLMs) has been made available for commercial use. However, their readiness to replace existing capabilities remains unclear, and a systematic approach to holistically evaluate these SLMs is not readily available. This paper presents a systematic evaluation methodology and a characterization of modern open-source SLMs and their trade-offs when replacing proprietary LLMs for a real-world product feature. We have designed SLaM, an open-source automated analysis tool that enables the quantitative and qualitative testing of product features utilizing arbitrary SLMs. Using SLaM, we examine the quality and performance characteristics of modern SLMs relative to an existing customer-facing implementation using the OpenAI GPT-4 API. Across 9 SLMs and their 29 variants, we observe that SLMs provide competitive results, significant performance consistency improvements, and a cost reduction of 5x~29x when compared to GPT-4.

Pre-training is notoriously compute-intensive and academic researchers are notoriously under-resourced. It is, therefore, commonly assumed that academics can't pre-train models. In this paper, we seek to clarify this assumption. We first survey academic researchers to learn about their available compute and then empirically measure the time to replicate models on such resources. We introduce a benchmark to measure the time to pre-train models on given GPUs and also identify ideal settings for maximizing training speed. We run our benchmark on a range of models and academic GPUs, spending 2,000 GPU-hours on our experiments. Our results reveal a brighter picture for academic pre-training: for example, although Pythia-1B was originally trained on 64 GPUs for 3 days, we find it is also possible to replicate this model (with the same hyper-parameters) in 3x fewer GPU-days: i.e. on 4 GPUs in 18 days. We conclude with a cost-benefit analysis to help clarify the trade-offs between price and pre-training time. We believe our benchmark will help academic researchers conduct experiments that require training larger models on more data. We fully release our codebase at: https://github.com/apoorvkh/academic-pretraining.

We provide a reproducible, end-to-end demonstration of vector search with OpenAI embeddings using Lucene on the popular MS MARCO passage ranking test collection. The main goal of our work is to challenge the prevailing narrative that a dedicated vector store is necessary to take advantage of recent advances in deep neural networks as applied to search. Quite the contrary, we show that hierarchical navigable small-world network (HNSW) indexes in Lucene are adequate to provide vector search capabilities in a standard bi-encoder architecture. This suggests that, from a simple cost-benefit analysis, there does not appear to be a compelling reason to introduce a dedicated vector store into a modern "AI stack" for search, since such applications have already received substantial investments in existing, widely deployed infrastructure.

Language models that are sensitive to external context can more effectively capture the speaking patterns of individuals with specific characteristics or in particular environments. However, obtaining and leveraging such annotations can be challenging. In this work, we show how to leverage rich character and film annotations to personalise language models in a scalable manner. Our best model can reduce perplexity by up to 6.5% compared to a parameter-matched language model. Our approach performs on par with speaker-specific fine-tuning when the fine-tuning data (i.e. past dialogue) for individual speakers is available. On top of that, it also generalises well to a scenario with no such data, relying on combinations of demographic characteristics expressed via metadata. Our findings are consistent across two corpora, one of which is also a contribution of this paper: Cornell-rich contains rich manual annotations for 863 speaking characters from the Cornell Movie Dialog Corpus, including features such as characteristic quotes and character descriptions, along with six automatically extracted metadata features for over 95% of the featured films. Finally, we also present a cost-benefit analysis highlighting which annotations are most cost-effective in reducing perplexity.

We study how document chunking choices impact the reliability of Retrieval-Augmented Generation (RAG) systems in industry. While practice often relies on heuristics, our end-to-end evaluation on Natural Questions systematically varies chunking method (token, sentence, semantic, code), chunk size, overlap, and context length. We use a standard industrial setup: SPLADE retrieval and a Mistral-8B generator. We derive actionable lessons for cost-efficient deployment: (i) overlap provides no measurable benefit and increases indexing cost; (ii) sentence chunking is the most cost-effective method, matching semantic chunking up to ~5k tokens; (iii) a "context cliff" reduces quality beyond ~2.5k tokens; and (iv) optimal context depends on the goal (semantic quality peaks at small contexts; exact match at larger ones).

Automatic machine translation metrics often use human translations to determine the quality of system translations. Common wisdom in the field dictates that the human references should be of very high quality. However, there are no cost-benefit analyses that could be used to guide practitioners who plan to collect references for machine translation evaluation. We find that higher-quality references lead to better metric correlations with humans at the segment-level. Having up to 7 references per segment and taking their average helps all metrics. Interestingly, the references from vendors of different qualities can be mixed together and improve metric success. Higher quality references, however, cost more to create and we frame this as an optimization problem: given a specific budget, what references should be collected to maximize metric success. These findings can be used by evaluators of shared tasks when references need to be created under a certain budget.

With Artificial Intelligence (AI) increasingly permeating various aspects of society, including healthcare, the adoption of the Transformers neural network architecture is rapidly changing many applications. Transformer is a type of deep learning architecture initially developed to solve general-purpose Natural Language Processing (NLP) tasks and has subsequently been adapted in many fields, including healthcare. In this survey paper, we provide an overview of how this architecture has been adopted to analyze various forms of data, including medical imaging, structured and unstructured Electronic Health Records (EHR), social media, physiological signals, and biomolecular sequences. Those models could help in clinical diagnosis, report generation, data reconstruction, and drug/protein synthesis. We identified relevant studies using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We also discuss the benefits and limitations of using transformers in healthcare and examine issues such as computational cost, model interpretability, fairness, alignment with human values, ethical implications, and environmental impact.

Purpose. Patients with advanced cancer may undergo multiple lines of treatment, switching therapies as their disease progresses. Motivated by a study of metastatic prostate cancer, we develop a microsimulation framework to study therapy sequence. Methods. We propose a discrete-time state transition model to study two lines of anti-cancer therapy. Based on digitized published progression-free survival (PFS) and overall survival (OS) curves, we infer event types (progression or death), and estimate transition probabilities using cumulative incidence functions with competing risks. Our model incorporates within-patient dependence over time, such that response to first-line therapy informs subsequent event probabilities. Parameters governing the degree of within-patient dependence can be used to calibrate the model-based results to those of a target trial. We demonstrate these methods in a study of two therapy sequences for metastatic prostate cancer, where Docetaxel (DCT) and Abiraterone Acetate (AA) are both appropriate for use in either first or second line treatment. We assess costs, Quality-Adjusted Life Years (QALYs) and Incremental Cost Effectiveness Ratio (ICER) for two treatment strategies: DCT then AA vs AA then DCT. Results. Using digitized survival curves from relevant clinical trials, we identified 8.6-13.9% of PFS times that should be categorized as deaths, allowing for estimation of cumulative incidence functions. Models assuming within-patient independence overestimated OS time, corrected with our calibration approach. Correction resulted in meaningful changes in the difference in QALYs between treatment strategies (0.07 vs 0.15) and the ICER (-\76,836/QALY vs -21,030/QALY). Conclusions. Microsimulation models can be successfully used to study cost-effectiveness of therapy sequences, taking care to account correctly for within-patient dependence.

The widespread adoption of AI systems in the economy hinges on their ability to generate economic value that outweighs their inference costs. Evaluating this tradeoff requires metrics that account for both performance and costs. We propose a framework grounded in production theory for evaluating language models by combining accuracy and inference cost. We introduce "cost-of-pass", the expected monetary cost of generating a correct solution. We then define the "frontier cost-of-pass" as the minimum cost-of-pass achievable across available models or the "human-expert, using the approximate cost of hiring an expert. Our analysis reveals distinct economic insights. First, lightweight models are most cost-effective for basic quantitative tasks, large models for knowledge-intensive ones, and reasoning models for complex quantitative problems, despite higher per-token costs. Second, tracking this frontier cost-of-pass over the past year reveals significant progress, particularly for complex quantitative tasks where the cost has roughly halved every few months. Third, to trace key innovations driving this progress, we examine counterfactual frontiers: estimates of cost-efficiency without specific model classes. We find that innovations in lightweight, large, and reasoning models have been essential for pushing the frontier in basic quantitative, knowledge-intensive, and complex quantitative tasks, respectively. Finally, we assess the cost-reductions afforded by common inference-time techniques like majority voting and self-refinement, finding that their marginal accuracy gains rarely justify their costs. Our findings underscore that complementary model-level innovations are the primary drivers of cost-efficiency, and our economic framework provides a principled tool for measuring this progress and guiding deployment.

We seek to identify the most relevant benefits offered by Medicare Advantage Health Plans that drive membership and market share. As an example, we explore plans operating in a single county in New Jersey between 2018 and 2023. A dataset of benefits from publicly available data sources was created and the variance inflation factor was applied to identify the correlation between the extracted features, to avoid multicollinearity and overparameterization problems. We categorized the variable Market Share and used it as a multinomial response variable with three categories: less than 0.3\%, 0.3\% to 1.5\%, and over 1.5\%. Categories were chosen to achieve approximately uniform distribution of plans (47, 60, and 65 respectively). We built a multinomial Lasso model using 5-fold cross-validation to tune the penalty parameter. Lasso forced some features to be dropped from the model, which reduces the risk of overfitting and increases the interpretability of the results. For each category, important variables are different. Certain brands drive market share, as do PPO plans and prescription drug coverage. Benefits, particularly ancillary benefits that are not part of CMS's required benefits, appear to have little influence, while financial terms such as deductibles, copays, and out-of-pocket limits are associated with higher market share. Finally, we evaluated the predictive accuracy of the Lasso model with the test set. The accuracy is 0.76.